Asbestos Review Program
Dedicated clinic for people who have worked with or had exposure to asbestos
It is known that people who have been exposed to asbestos have a greater chance (but still a small one) of developing cancer of the lung and mesothelioma (cancer of the lining of the lung). At present, the only known actions that can be taken to reduce these risks are to stop smoking and avoid further contact with asbestos.
The Asbestos Review Program
The Asbestos Review Program (ARP) is a dedicated clinic to follow up people who have worked with, or who have had significant exposure to, asbestos.
The clinic has been running since 1990 and specialises in dealing with asbestos-related lung diseases. At the ARP we arrange an annual health check-up using specialist breathing tests, blood tests and, the latest CT scan technology.
The careful use of a low-dose CT scans of the chest can identify lung cancer at an early stage when it is potentially curable and the ARP offers this test. We also have many years of experience in dealing with other lung diseases that asbestos exposure can cause.
How to get access to the program
Joining the Asbestos Review Program
The clinic can only accept people who have worked in a job where they have been exposed to asbestos for more than 3-months of full-time work. We also look after those who have x-rays or CT scans showing evidence of asbestos exposure (usually ‘pleural plaques’) and those who ever worked or lived in the asbestos mining town of Wittenoom.
What happens next?
An appointment will be made for you to attend our clinic in the Department of Respiratory Medicine, Ground floor, B-block, Sir Charles Gairdner Hospital. You will also be asked to attend for a CT scan at Envision Medical Imaging in Subiaco. Information forms will be sent to you to complete at home and bring with you. The first appointment forms are quite detailed and may take up to 45 minutes to complete, after this the annual forms are much quicker.
The ARP Team
- A/Prof Fraser Brims
- Clin/Prof Bill Musk
- Prof Nick de Klerk
- Dr Ed Harris
- Dr Peter Franklin
- A/Prof Alison Reid
- Deb Hall
- Lucie Conte
- Nola Olsen
- Annette McWilliams, Fraser Brims, Nanda Horeweg, Harry de Koning, James Jet. Lung Cancer Screening (chapter 7). International Association for the Study of Lung Cancer, Thoracic Oncology Textbook, 2nd Edition, 2017.
- Manners, D., Wong, P., Murray, C., Teh, J., Kwok, Y. J., de Klerk, N., . . . Brims, F. J. H. (2017). Correlation of ultra-low dose chest CT findings with physiologic measures of asbestosis. EUROPEAN RADIOLOGY, 27(8), 3485-3490. doi:10.1007/s00330-016-4722-7
- Brims, F. J. H. (2017). Integrated care for resected early stage lung cancer: innovations and exploring patient needs. BMJ Open Respiratory Research, 4, e000175. doi:10.1136/bmjresp-2016-000175
- Weber, M., Yap, S., Goldsbury, D., Manners, D., Tammemagi, M., Marshall, H., . . . Canfell, K. (2017). Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO m2012 risk prediction tool. International Journal of Cancer, 141(2), 242-253. doi:10.1002/ijc.30673
- Murray, C. P., Wong, P. M., Teh, J., de Klerk, N., Rosenow, T., Alfonso, H., . . . Brims, F. J. H. (2016). Ultra low dose CT screen-detected non-malignant incidental findings in the Western Australian Asbestos Review Programme. Respirology, 21(8), 1419-1424. doi:10.1111/resp.12826
- Manners, D., Hui, J., Hunter, M., James, A., Knuiman, M. W., McWilliams, A., . . . Brims, F. J. H. (2016). Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry. Medical Journal of Australia, 204(11), 406.e1-406.e6. doi:10.5694/mja16.00043
- Manners, D., Emery, J., Brims, F. J., & Pettigrew, S. (2016). Lung cancer screening – Practical challenges of confining participation to those who might benefit. Australian and New Zealand Journal of Public Health, 40(3), 205-206. doi:10.1111/1753-6405.12516
- Brims, F., McWilliams, A., & Fong, K. (2016). Lung cancer screening in Australia: Progress or procrastination?: There is progress internationally with lung cancer screening but far slower headway in Australia. Medical Journal of Australia, 204(1), 4-4.e1. doi:10.5694/mja15.01109
- Manners, D., Emery, J., Brims, F., & Pettigrew, S. F. (2016). Lung Cancer Screening – Policy challenges of confining participation to those that might benefit. Australian and New Zealand Journal of Public Health, 40(3), 205-206. doi:10.1111/1753-6405.12516
- Brims, F. J. H., Murray, C. P., De Klerk, N., Alfonso, H., Reid, A., Manners, D., . . . Musk, A. W. (2015). Ultra-low-dose chest computer tomography screening of an asbestos-exposed population in Western Australia. American Journal of Respiratory and Critical Care Medicine, 191(1), 113-116.
- Brims, F., Musk, B., Reid, A., Pang, S. C., Franklin, P., Peters, S., & De Klerk, N. (2015). Presence of pleural plaques and/or asbestosis and the risk of lung cancer in a Crocidolite asbestos exposed population from Western Australia. In Journal of Thoracic Oncology Vol. 10 (pp. S613).
- McWilliams A, Tammemagi M, Mayo JR, Lam S, Roberts H, Liu G et al. Malignancy risk of pulmonary nodules detected on first screening CT. NEJM, 2013; 369:910-919.
- Cressman S, Lam S, Tammemagi M, Evans W, Leighl N, Regier D, Bolbocean C, Shepherd F, Tsao MS, Manos D, Liu G, Atkar-Khattra S, Cromwell I, Johnson M, Mayo J, McWilliams A, Couture C, English J, Goffin J, Hwang D, Puksa S, Roberts H, Tremblay A, MacEachern P, Burrowes P, Bhatia R, Finley R, Goss G, Nicholas G, Seely J, Sekhon H, Yee J, Amjadi K, Cutz JC, Ionescu D, Yasufuku K, Martel S, Soghrati K, Sin D, Tan W, Urbanski S, Xu Z, Peacock S. On behalf of the Pan-Canadian Early Detection of Lung Cancer Study Team. Resource Utilisation and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography In Canada. JTO, 2014;9(10):1449-1458.
- McWilliams A, Beigi P, Srinidhi A, Lam S, MacAulay C. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers using an Electronic Nose. IEEE Transactions on Biomedical Engineering, 2015;62(8):2044-2054. DOI: 10.1109/TBME.2015.2409092
- McWilliams A. Does AQuIRE challenge the role of navigational bronchoscopy for peripheral pulmonary lesions? Ann Tranl Med, 2016;4(20):406.